Stay updated on Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial page.

Latest updates to the Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial page
- Check6 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to transition updates and FAQs.SummaryDifference1%

- Check20 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2; the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 error.SummaryDifference0.2%

- Check47 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study content and related details. Until resolved, users cannot view the study record or associated information on that page.SummaryDifference20%

- Check68 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, signaling a minor update to the page template or its accompanying information.SummaryDifference0.1%

Stay in the know with updates to Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial page.